FOXA1 and adrenal cortex carcinoma: The Kaplan-Meier survival analysis revealed that high FOXA1 expression predicted worse overall survival of patients with ACC, BRCA, KIRC, KIRP, LGG, MESO, SARC, SKCM, and THCA (Figures 4(a)–4(i)) while better survival of patients with BLCA, COAD, and PAAD (Figures 4(j)–4(l)).